Covid-19 and HIV: Not Always an Unfavorable Combination

preprint OA: gold CC-BY-4.0
🔓 Open OA copy View at publisher

Abstract

Background: A 73-years-old-man patient who had a history of Human Immunodefiency Virus (HIV) infection for over 20 years was diagnosed with SARS-CoV-2 infection.Case presentationThe patient was admitted to the Intensive Care Unit (ICU), where he remained for 25 days, due to a severe condition. Intubation, hemodialysis and tracheostomy were necessary to maintain homeostasis. In addition to regular treatment with etravirine, dolutegravir, darunavir and ritonavir for highly active antiretroviral therapy, the patient received To-cilizumab, which showed a great recovery in the patient's condition.ConclusionThe patient had several risk factors, such as: male gender, age> 70 years and hypertension. The use of To-cilizumab was of great importance in the patient's recovery, since the drug increased his immune response, which is deficient, due to HIV infection.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0